Study Of Ispinesib In Subjects With Breast Cancer

Clinical trial NCT00089973 · COMPLETED

Trial details

NCT number: NCT00089973
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2004-06-30
Primary completion: 2006-08-25
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.